In a mouse model of DN induced by Streptozotozin (STZ) injections, we show that diabetic Arfip2 KO mice have significantly increased ACR levels compared to diabetic heterozygous controls (Figure 8A–D), suggesting that Arfip2 deficiency deteriorates DN and further affects kidney function. Here, ARFIP2 is linked to liver dysplastic nodule.